At Booth 534 Lonza will showcase how its automated QC testing solutions and Nucleofector™ Devices can increase efficiency and throughput in the drug development process. In addition, Lonza is supporting a roundtable discussion on advanced in vitro cancer models for drug discovery and development.....
Original Article: Lonza to Showcase Its Latest Solutions for Enhanced QC Testing and Transfection at SLAS2018
NEXT ARTICLE